pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,781 catalysts · 5,539 phase readout · 2,324 8k filing · 241 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 76 catalysts2026-08-05: 18 catalysts2026-08-06: 12 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 1 catalyst2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: adcom×type: phase readout×clear all
type
  • phase readout5,539
  • 8k filing2,324
  • earnings241
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT03949153: Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis

Sponsor: University Hospital, Strasbourg, France. Phase: PHASE1. Conditions: Melanoma (Skin)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05338437: NMES in HF Patients to Improve Functional Recovery Following Hospitalization

Sponsor: University of Vermont Medical Center. Phase: NA. Conditions: Heart Failure With Preserved Ejection Fraction

full page →ctgov ↗
›RECRUITINGphase readoutNCT06792045: Prediction of Tongue Base Obstruction During Sleep

Sponsor: Université Catholique de Louvain. Phase: . Conditions: Obstructive Sleep Disordered Breathing

full page →ctgov ↗
›COMPLETEDphase readoutNCT05171972: Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment

Sponsor: University of Southern California. Phase: . Conditions: Relapsing Remitting Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06794372: [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas

Sponsor: John O. Prior. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma HNSCC

full page →ctgov ↗
›COMPLETEDphase readoutNCT07382895: The Relationship Between the ASA Score Determined by Operating Room Nurses and Intubation Duration

Sponsor: Zonguldak Bulent Ecevit University. Phase: . Conditions: The Individual Must be 18 Years of Age or Older, The Individual Must be Willing to Participate in the Study

full page →ctgov ↗
›COMPLETEDphase readoutNCT05612295: Mindfulness-Based Peak Performance, Endurance Performance Under Pressure, Performance-relevant Mental Attributes

Sponsor: National Taiwan Normal University. Phase: NA. Conditions: Mindfulness, Sport Performance, Neurocognitive Function, Stress

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05903339: Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Hiv

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06852339: Evaluating the EAPOC-COPD System

Sponsor: Women's College Hospital. Phase: NA. Conditions: COPD

full page →ctgov ↗
›COMPLETEDphase readoutNCT07383077: Molecular Determinants of Spinal Cord Injury Rehabilitation

Sponsor: Prof. Sandra Vieira. Phase: . Conditions: Spinal Cord Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07637396: Ankle-Brachial Index Changes Post Exercise and Its Effects on Patient-Centered Outcomes and Gait

Sponsor: Louisiana State University Health Sciences Center Shreveport. Phase: . Conditions: Peripheral Arterial Disease(PAD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05110846: A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

Sponsor: Carmot Therapeutics, Inc.. Phase: PHASE2. Conditions: Obesity, Overweight, Type 2 Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT06404762: Tuberosity Versus Palatal Connective Tissue Graft on the Treatment of Single Maxillary Recession-type Defects

Sponsor: Gazi University. Phase: NA. Conditions: Gingival Recession, Localized

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05448846: Exercise Program for Colorectal Older Patients

Sponsor: Hospital General Universitario Gregorio Marañon. Phase: NA. Conditions: Colorectal Neoplasms, Aged

full page →ctgov ↗
›COMPLETEDphase readoutNCT06535646: Digital Health Technology for People With Mitochondrial Disease

Sponsor: Neuroscience Research Australia. Phase: NA. Conditions: Mitochondrial Diseases

full page →ctgov ↗
›COMPLETEDphase readoutNCT07186946: Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, PK, PD, and Comparative Bioavailability of THRV-1268 in Obese Adult Participants

Sponsor: Thryv Therapeutics, Inc.. Phase: PHASE1. Conditions: Heart Failure

full page →ctgov ↗
›AVAILABLEphase readoutNCT07647627: Availability of Dibotatug (DR-01) Outside Clinical Trials Via Expanded Access for Eligible Participants

Sponsor: Dren Bio. Phase: . Conditions:

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07621770: Nutritional Status in Adults With Diabetic Foot Ulcers

Sponsor: Hvidovre University Hospital. Phase: . Conditions: Diabetic Foot Ulcers (DFU), Nutrition Assessment, Malnutrition (Calorie), Ulcer Foot, Dietary Intake Assessment, Bio-Impedance Measurements, Wound Healing

full page →ctgov ↗
›COMPLETEDphase readoutNCT06196073: Visceral Osteopathy in Functional Constipation

Sponsor: Pamukkale University. Phase: NA. Conditions: Functional Constipation

full page →ctgov ↗
›COMPLETEDphase readoutNCT06381973: Ventilation Distribution in COPD Patients During Breathing Exercises

Sponsor: William Poncin, PT, PhD. Phase: NA. Conditions: Chronic Obstructive Pulmonary Disease, Healthy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07337369: Cultural Adaptation of CBTi for the Arab World

Sponsor: Laval University. Phase: NA. Conditions: Insomnia Disorder, Insomnia, Cultural Adaptation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07326969: MOVEMENT ANALYSIS IN PATIENTS UNDERGOING VERTEBRECTOMIES FOR SPINE ONCOLOGY: A PILOT STUDY

Sponsor: Istituto Ortopedico Rizzoli. Phase: . Conditions: Spine Tumor, Vertebral Metastasis, Vertebral Column Mass

full page →ctgov ↗
›RECRUITINGphase readoutNCT07356583: Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Enterovirus, Clinical Syndrome, Respiratory Complications, Gastrointestinal, Sepsis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05648383: Promote Health With Digital Tools Among Adults With Type 2 Diabetes/Prediabetes and/or Hypertension

Sponsor: Harokopio University. Phase: NA. Conditions: Type 2 Diabetes, PreDiabetes, Hypertension, Obesity & Overweight

full page →ctgov ↗
›TERMINATEDphase readoutNCT05975905: A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Sponsor: Keros Therapeutics, Inc.. Phase: PHASE2. Conditions: Pulmonary Arterial Hypertension

full page →ctgov ↗
›COMPLETEDphase readoutNCT07686705: Intravenous Versus Intra-articular Tranexamic Acid for Visual Clarity During Arthroscopic Rotator Cuff Repair

Sponsor: Konkuk University Medical Center. Phase: NA. Conditions: Rotator Cuff Tears

full page →ctgov ↗
›COMPLETEDphase readoutNCT07305805: A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes

Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›RECRUITINGphase readoutNCT07597005: Red Propolis Supplementation as a Strategy in Chronic Kidney Disease

Sponsor: Universidade Federal Fluminense. Phase: NA. Conditions: Kidney Disease, Oxidative Stress, Chronic Kidney Disease, Inflammation

full page →ctgov ↗
›COMPLETEDphase readoutNCT05260905: Predictors of Affective Responses to Sprint Interval Exercise

Sponsor: University of Stirling. Phase: . Conditions: General Health

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06305754: Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer (NSCLC)

full page →ctgov ↗
›TERMINATEDphase readoutNCT04809766: Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE1. Conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT07481266: Single-Window Versus Two-Window Posterolateral Approach for Malleolar Fractures

Sponsor: muhammed kılıç. Phase: NA. Conditions: Ankle Fractures, Posterior Malleolus Fractures, Lateral Malleolus Fracture

full page →ctgov ↗
›COMPLETEDphase readoutNCT04612166: Medication Empowerment and Deprescription for Safety (MEDS) Study

Sponsor: University of Iowa. Phase: NA. Conditions: Aging, Fall Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT03446456: Vasopressin and Pain Perception in the Brain

Sponsor: University of Maryland, Baltimore. Phase: PHASE1. Conditions: Acute Pain

full page →ctgov ↗
›TERMINATEDphase readoutNCT03741751: Repetitive TMS & Cognitive Training in Adults With Schizophrenia

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Schizophrenia Spectrum and Other Psychotic Disorders, Cognitive Impairment

full page →ctgov ↗
›COMPLETEDphase readoutNCT07617051: PPIVMs for Cervicogenic Headache

Sponsor: Jordan University of Science and Technology. Phase: NA. Conditions: Cervicogenic Headache

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07588529: Is Nipple Stimulation Effective for Inducing Labor and Acceptable to Patients, Nurses, and Providers?

Sponsor: University of Kansas Medical Center. Phase: NA. Conditions: Pregnancy, Induction of Labor

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07367945: Incentive Spirometry Versus Inspiratory Muscle Training After Coronary Artery Bypass Grafting

Sponsor: Cairo University. Phase: NA. Conditions: Coronary Artery Bypass Graft (CABG)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05331872: Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology. Phase: PHASE1. Conditions: Liver Cirrhosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04547595: Hypnosis Intervention for the Management of Pain Perception During Joint Lavage

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Knee Osteoarthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05863195: Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE3. Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Carcinoma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04899895: Rheumatology Biorepository

Sponsor: CorEvitas. Phase: . Conditions: Rheumatoid Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05897775: Coordinated Reset Deep Brain Stimulation for Essential Tremor

Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Essential Tremor, Upper Extremity Essential Tremor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07394257: Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis

Sponsor: Minia University. Phase: NA. Conditions: Bacterial Keratitis, Recalcitrant Infectious Keratitis, Corneal Ulcer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06295757: Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures

Sponsor: Masonic Cancer Center, University of Minnesota. Phase: NA. Conditions: Tobacco Use, Cigarette Smoking, Nicotine Dependence

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07676201: One-year Prognostic Impact of Microcirculation Assessed by NH IMR Angio in Patients Hospitalized for Acute Myocarditis

Sponsor: University Hospital, Grenoble. Phase: . Conditions: Myocarditis Acute

full page →ctgov ↗
›RECRUITINGphase readoutNCT05344001: Life After Sport: Prior Injury and Sedentary Behavior as Mechanisms of Later Poor Health

Sponsor: Marquette University. Phase: . Conditions: Aging, Athletic Injuries, Physical Inactivity, Knee Injuries and Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT07287501: Efficacy of Pain Science Education Combined With Exercise in Older Adults With Chronic Pain

Sponsor: University of Salamanca. Phase: NA. Conditions: Chronic Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07485101: Glycemic Targets During CPB in Elderly Diabetes

Sponsor: Beijing Anzhen Hospital. Phase: NA. Conditions: Glycemic Management During CPB in Elderly Diabetic Cardiac Surgery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02912312: Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7

full page →ctgov ↗
← prev
page 106 of 116
next →